Cheng‐Chung Tsai

472 total citations
16 papers, 322 citations indexed

About

Cheng‐Chung Tsai is a scholar working on Surgery, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cheng‐Chung Tsai has authored 16 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Hepatology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cheng‐Chung Tsai's work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Cheng‐Chung Tsai is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Cheng‐Chung Tsai collaborates with scholars based in Taiwan. Cheng‐Chung Tsai's co-authors include I-Shu Chen, Being‐Whey Wang, Yu‐Chia Chen, Shiuh‐Inn Liu, King‐Tong Mok, Nan–Hua Chou, Huei‐Lung Liang, Ming-Hsin Yeh, Ping‐I Hsu and Gin‐Ho Lo and has published in prestigious journals such as Sensors, Journal of the American College of Surgeons and Oncotarget.

In The Last Decade

Cheng‐Chung Tsai

16 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng‐Chung Tsai Taiwan 9 179 170 104 90 82 16 322
Alessandro Germini Italy 10 247 1.4× 163 1.0× 115 1.1× 60 0.7× 75 0.9× 21 378
S. Vavassori Italy 10 236 1.3× 190 1.1× 132 1.3× 131 1.5× 104 1.3× 19 399
Andrea Cacciato Insilla Italy 12 153 0.9× 264 1.6× 83 0.8× 87 1.0× 152 1.9× 26 435
Eleonora Guzzetti Italy 10 287 1.6× 248 1.5× 65 0.6× 128 1.4× 192 2.3× 13 430
O. Bouché France 8 125 0.7× 72 0.4× 59 0.6× 62 0.7× 138 1.7× 26 261
Suzanne Darby United Kingdom 7 111 0.6× 158 0.9× 88 0.8× 217 2.4× 117 1.4× 14 404
Wei‐Fan Hsu Taiwan 12 220 1.2× 90 0.5× 193 1.9× 66 0.7× 49 0.6× 45 365
Takuya Hiwaki Japan 8 325 1.8× 126 0.7× 233 2.2× 98 1.1× 40 0.5× 12 413
H. Hokotate Japan 7 213 1.2× 158 0.9× 170 1.6× 66 0.7× 38 0.5× 16 355
Yoshirou Baba Japan 6 307 1.7× 128 0.8× 218 2.1× 63 0.7× 38 0.5× 9 393

Countries citing papers authored by Cheng‐Chung Tsai

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Chung Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Chung Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Chung Tsai more than expected).

Fields of papers citing papers by Cheng‐Chung Tsai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Chung Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Chung Tsai. The network helps show where Cheng‐Chung Tsai may publish in the future.

Co-authorship network of co-authors of Cheng‐Chung Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Chung Tsai. A scholar is included among the top collaborators of Cheng‐Chung Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Chung Tsai. Cheng‐Chung Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Li, Mingfeng, Huei‐Lung Liang, Chia‐Ling Chiang, et al.. (2022). New Regimen of Combining Hepatic Arterial Infusion Chemotherapy and Lipiodol Embolization in Treating Hepatocellular Carcinoma with Main Portal Vein Invasion. Journal of Personalized Medicine. 13(1). 88–88. 3 indexed citations
2.
Wu, Chien-Min, et al.. (2021). Portable Interactive Pulse Tactile Recorder and Player System. Sensors. 21(13). 4339–4339. 2 indexed citations
3.
Liao, Cheng-I, et al.. (2021). Leiomyomatosis peritonealis disseminata mimicking peritoneal carcinomatosis 13 years after laparoscopic uterine myomectomy. International Journal of Surgery Case Reports. 81(C). 105745–105745. 8 indexed citations
4.
Huang, Shiu‐Feng, Il‐Chi Chang, Tseng‐Chang Yen, et al.. (2018). Metabolic risk factors are associated with non‐hepatitis B non‐hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B. Hepatology Communications. 2(6). 747–759. 34 indexed citations
5.
Sun, Wei‐Chih, I-Shu Chen, Huei‐Lung Liang, et al.. (2017). Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resection. Oncotarget. 8(61). 104571–104581. 27 indexed citations
6.
Tsai, Cheng‐Chung, Chia‐Ling Chiang, Huei‐Lung Liang, et al.. (2017). Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment. International Journal of Surgery. 45. 35–41. 32 indexed citations
7.
Wang, Being‐Whey, Shiuh‐Inn Liu, Nan–Hua Chou, et al.. (2012). Number of involved lymph nodes is important in the prediction of prognosis for primary duodenal adenocarcinoma. Journal of the Chinese Medical Association. 75(11). 573–580. 20 indexed citations
8.
Liu, Shiuh‐Inn, et al.. (2012). An unusual cause of haematemesis: Left-sided portal hypertension due to a large pancreatic tumour. Digestive and Liver Disease. 44(6). e12–e12. 8 indexed citations
9.
Chan, Hoi‐Hung, Kwok‐Hung Lai, Chiun‐Ku Lin, et al.. (2011). Endoscopic papillary large balloon dilation alone without sphincterotomy for the treatment of large common bile duct stones. BMC Gastroenterology. 11(1). 69–69. 53 indexed citations
10.
Mok, King‐Tong, Shiuh‐Inn Liu, Shiu-Feng Huang, et al.. (2010). Hepatitis B Genotype C Correlated with Poor Surgical Outcomes for Hepatocellular Carcinoma. Journal of the American College of Surgeons. 211(5). 580–586. 17 indexed citations
11.
Tsai, Tzung‐Jiun, Kwok‐Hung Lai, Ping‐I Hsu, Cheng‐Chung Tsai, & Ting‐Ying Fu. (2009). Gallbladder Cancer Manifesting as Recurrent Common Bile Duct Stone and Duodenal Ulcer Bleeding. Journal of the Chinese Medical Association. 72(8). 434–437. 3 indexed citations
12.
Wang, Being‐Whey, King‐Tong Mok, Shiuh‐Inn Liu, et al.. (2008). Is Hepatectomy Beneficial in the Treatment of Multinodular Hepatocellular Carcinoma?. Journal of the Formosan Medical Association. 107(8). 616–626. 28 indexed citations
13.
Chou, Nan–Hua, King‐Tong Mok, Being‐Whey Wang, et al.. (2005). Intestinal Obstruction in Patients with Previous Laparotomy for Non-Malignancy. Journal of the Chinese Medical Association. 68(7). 327–332. 4 indexed citations
14.
Mok, King‐Tong, Being‐Whey Wang, Gin‐Ho Lo, et al.. (2003). Multimodality management of hepatocellular carcinoma larger than 10 cm. Journal of the American College of Surgeons. 197(5). 730–738. 63 indexed citations
15.
Pan, Huay‐Ben, et al.. (2001). Solitary Fibrous Tumor of the Liver: A Case Report. 26(4). 191–195. 1 indexed citations
16.
Wang, Being‐Whey, King‐Tong Mok, Hong‐Tai Chang, et al.. (1998). APACHE II Score: A Useful Tool for Risk Assessment and an Aid to Decision-Making in Emergency Operation for Bleeding Gastric Ulcer. Journal of the American College of Surgeons. 187(3). 287–294. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026